论文部分内容阅读
肺癌的发病率逐年上升,已成为我国发病率及死亡率第一位的恶性肿瘤。糖尿病的发病率也逐年攀升,直接影响了人们的生活质量及寿命。肺癌与糖尿病可通过多种机制相互促进,相互影响,加重患者病情,因而受到了人们的重视。一、肺癌引起血糖升高的机制有研究显示,肺癌患者中糖尿病发病率较一般人群高,且在化疗期间常出现血糖的进一步升高,如化疗后病情缓解,血糖水平又可下降。提示在肺癌患者中,血糖水平与化疗及病情的进展或缓解相关[1]。肺癌患者血糖水平升高的
The incidence of lung cancer increased year by year, has become China’s morbidity and mortality of the first malignant tumor. The incidence of diabetes is also rising year by year, directly affecting people’s quality of life and life expectancy. Lung cancer and diabetes can be promoted through a variety of mechanisms, mutual influence, increase the patient’s condition, which has attracted people’s attention. First, the mechanism of lung cancer caused by elevated blood sugar Some studies have shown that the incidence of diabetes in patients with lung cancer than the general population is high, and during chemotherapy often appear to further increase blood sugar, such as chemotherapy after remission, blood glucose levels can be reduced. Tip in patients with lung cancer, blood glucose levels and chemotherapy and disease progression or mitigation [1]. Lung cancer patients with elevated blood glucose levels